Evidence map›Paper›PMID 28116872›Full record

ReviewEndocrinology and metabolism (Seoul, Korea)2017

Recent Insights into Insulin-Like Growth Factor Binding Protein 2 Transcriptional Regulation.

Minsang Shin, Hye Suk Kang, Jae Hyung Park, Jae Hoon Bae, Dae Kyu Song, Seung Soon Im

Open access · diamondAbstract readReview
In one paragraph

Review in Endocrinology and metabolism (Seoul, Korea), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. IGFBP2-Ceramide Pathway Mediates Divergent Myelin Breakdown in the PNS and CNS Following Injury.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2023
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Minsang ShinDepartment of Microbiology, Kyungpook National University School of Medicine, Daegu, Korea.ORCID http://orcid.org/0000-0001-8679-446X
Hye Suk KangDepartment of Physiology, Keimyung University School of Medicine, Daegu, Korea.ORCID http://orcid.org/0000-0001-7568-3211
Jae Hyung ParkDepartment of Physiology, Keimyung University School of Medicine, Daegu, Korea.
Jae Hoon BaeDepartment of Physiology, Keimyung University School of Medicine, Daegu, Korea.
Dae Kyu SongDepartment of Physiology, Keimyung University School of Medicine, Daegu, Korea.
Seung Soon ImDepartment of Physiology, Keimyung University School of Medicine, Daegu, Korea. ssim73@kmu.ac.kr.ORCID http://orcid.org/0000-0002-2743-2108
Keimyung University · KRKyungpook National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin-like growth factor binding proteins (IGFBPs) are major regulators of insulin-like growth factor bioavailability and activity in metabolic signaling. Seven IGFBP family isoforms have been identified. Recent studies have shown that IGFBPs play a pivotal role in metabolic signaling and disease, including the pathogenesis of obesity, diabetes, and cancer. Although many studies have documented the various roles played by IGFBPs, transcriptional regulation of IGFBPs is not well understood. In this review, we focus on the regulatory mechanisms of IGFBP gene expression, and we summarize the findings of transcription factor activity in the IGFBP promoter region.

Indexed as

Insulin-like growth factor binding protein 2LiverMetabolic diseasesTranscriptional regulation

Identifiers

PMID28116872
PMCPMC5368109
OpenAlexW2583388739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.